Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2001. Start Trial.
Date Value
March 31, 2024 -1.73K%
December 31, 2023 -51.56%
September 30, 2023 -0.68%
June 30, 2023 -11.25%
March 31, 2023 -3.98%
December 31, 2022 34.38%
September 30, 2022 53.57%
June 30, 2022 63.01%
March 31, 2022 69.74%
December 31, 2021 57.37%
September 30, 2021 20.23%
June 30, 2021 20.63%
March 31, 2021 25.17%
December 31, 2020 19.92%
September 30, 2020 25.94%
June 30, 2020 17.50%
March 31, 2020 11.91%
December 31, 2019 18.29%
September 30, 2019 20.83%
June 30, 2019 22.75%
March 31, 2019 21.68%
December 31, 2018 22.22%
September 30, 2018 33.39%
June 30, 2018 30.40%
March 31, 2018 18.62%
Date Value
December 31, 2017 53.00%
September 30, 2017 24.68%
June 30, 2017 25.98%
March 31, 2017 25.58%
December 31, 2016 26.35%
September 30, 2016 19.35%
June 30, 2016 22.01%
March 31, 2016 31.15%
December 31, 2015 23.72%
September 30, 2015 36.14%
June 30, 2015 24.38%
March 31, 2015 25.32%
December 31, 2014 14.04%
September 30, 2014 14.57%
June 30, 2014 17.97%
March 31, 2014 22.50%
December 31, 2013 21.99%
September 30, 2013 25.71%
June 30, 2013 22.80%
March 31, 2013 24.24%
December 31, 2012 24.39%
September 30, 2012 24.07%
June 30, 2012 22.08%
March 31, 2012 21.78%
December 31, 2011 18.66%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
CompuMed, Inc. 49.53%
Globaltech Holdings, Inc. --
eWellness Healthcare Corp. --
Renalytix Plc --
RadNet, Inc. 7.89%